Navigation Links
Nektar Therapeutics Reports Third Quarter 2010 Financial Results

2NEKTAR THERAPEUTICSCONDENSED CONSOLIDATED BALANCE SHEETS(In thousands)(Unaudited)ASSETSSeptember 30, 2010December 31, 2009 (1)Current assets:Cash and cash equivalents

49,597Short-term investments

290,396346,614Accounts receivable


11,4606,471Other current assets

6,1196,183Total current assets

413,666Property and equipment, net


76,50176,501Other assets

1,8557,088Total  assets

575,518LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Accounts payable

3,066Accrued compensation

10,55210,052Accrued expenses

12,3524,354Accrued clinical trial expenses

12,75914,167Deferred revenue, current portion

40,232115,563Interest payable

581,805Other current liabilities

4,4764,009Total current liabilities

53,016Convertible subordinated notes

214,955214,955Capital lease obligations

17,40218,800Deferred revenue

69,03376,809Deferred gain

4,3715,027Other long-term liabilities

4,9364,544Total liabilities

473,151Commitments and contingenciesStockholders' equity:Preferred stock

-Common stock

99Capital in excess of par value

1,347,8001,327,942Accumulated other comprehensive income

1,1051,025Accumulated deficit

(1,241,967)(1,226,609)Total stockholders' equity

2,367Total liabilities and stockholders' equity

575,518(1) The consolidated balance sheet at December 31, 2009 has been derived from the audited financial statements at that date but does not include all of the information and notes required by generally accepted accounting principles in the United States for complete financial statements. NEKTAR THERAPEUTICSCONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(In thousands, except per share

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Nektar to Announce Financial Results for the Third Quarter of 2010 on Thursday, November 4, 2010, After Close of U.S.-Based Financial Markets
2. Nektar Presents New Preclinical Data on NKTR-181 at Anesthesiology 2010
3. Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer
4. Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug-Drug Interaction Profile for NKTR-118
5. Nektar Therapeutics Reports Second Quarter 2009 Financial Results
6. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
7. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
8. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
9. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
10. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
11. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
Post Your Comments:
(Date:7/2/2015)... , July 2, 2015 Roche,s Bloodhound ... high-growth market segment in hematology testing, according to ... that Roche,s recent unveiling of its Bloodhound digital cell ... cobas m 511 hematology analyzer – is ... growth enjoyed by current leader CellaVision, but also ...
(Date:7/2/2015)... July 2, 2015  The Green Exchange, Inc., the ... first HIPAA compliant mobile app that connects cannabis growers ... medical marijuana, announced today that their service provides the ... Meadow and more than half a dozen other delivery ... Loud Cannabis is unique in that it connects ...
(Date:7/2/2015)... 2015 The report "Silage Inoculants ... (Lactobacillus, Pediococcus & Enterococcus), Enzymes (Fibre-digesting & Starch-digesting), Crop-type ... Silage Inoculants & Enzymes Market is expected to reach ... from 2015 to 2020. Browse 75 ... 194 P ages and an in-depth ...
Breaking Medicine Technology:Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 3New Cannabis Delivery App Gets Product to Patient in Under 7 Minutes 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 3Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 4
... Novavax, Inc. (Nasdaq: NVAX ) announced today ... its virus-like-particle (VLP) H1N1 influenza vaccine in Mexico in ... Avimex distributes biological and pharmaceutical products for use in ... world. Avimex is providing financial support for the ...
... , SHENYANG, China, Oct. 20 ... "Company"), a leading China-based biotechnology,company focused on researching, developing, ... its annual general,meeting of shareholders held on October 12, ... the Company,s shareholders re-elected Dr. Jing Lou and Mr.,Moujia ...
Cached Medicine Technology:Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico 2Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico 3Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico 4Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico 5
(Date:7/3/2015)... ... July 03, 2015 , ... ... healthcare providers, has been retained to lead a national chief nursing officer ... top-ranked executive search firms in the healthcare industry, B. E. Smith has recently ...
(Date:7/3/2015)... ... , ... First Choice Emergency Room , the largest network of independent ... new Medical Director of its Frisco facility. , “We are pleased to announce that ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:7/2/2015)... ... 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased to announce the opening ... store located in Mississippi. The premium frozen yogurt chain was listed as #22 on ... at 104 Railroad Avenue, New Albany, MS 38652, will have a grand opening event ...
(Date:7/2/2015)... WIsconsin (PRWEB) , ... July 02, 2015 , ... ... for the parking structure retrofit project at the University of Minnesota, they knew ... is that it would also be an award-winning choice: the total energy savings ...
(Date:7/2/2015)... ... July 02, 2015 , ... As Americans celebrate the Fourth of July outdoors ... is on the rise. July is UV Safety Month, and physicians at American Family ... of getting skin checks. Experts say most skin cancers can be found early with ...
Breaking Medicine News(10 mins):Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3Health News:sweetfrog Opens First Location in Mississippi 2Health News:Kenall’s TekDek™ Helps University Achieve Award-Winning Energy Savings in Parking Structure Lighting Retrofit 2Health News:Local Physicians Warn of Holiday Health Hazards 2Health News:Local Physicians Warn of Holiday Health Hazards 3Health News:Local Physicians Warn of Holiday Health Hazards 4
... concept catching up fast in the West. ,With the ... phones with hundreds of names and numbers stored in its ... these numbers belong to the near and dear. ,In ... had a heart attack and the physicians attending on the injured ...
... La Jolla Institute for Allergy & Immunology (LIAI) made ... new therapeutic approach for treating autoimmune and inflammatory diseases ... ,.The studies, conducted in laboratory mice, demonstrated ... Vitamin A is broken down in the body, in ...
... Yarra River, posing serious threat to wildlife in the region ... the water until the slick - from the Chandler Highway ... ,The Environment Protection Agency (EPA) is investigating the source of ... was not discovered until Tuesday by a kayaker using the ...
... the University of Illinois at Chicago and Cornell University ... in patients who suffer from Neurodegenerative diseases or stroke ... cellular events take place that lead to the death ... enzymes called histone deacetylases can modulate gene expression, and ...
... revealed that drug letrozole, which is used to treat breast ... from Ovarian cancer by three years. ,The researcher used ... ,Though the discovery may not benefit all because not ... silent killer are triggered by oestrogen, it still offers hope ...
... The Chandigarh administration, planning to make the city 'smoke-free' from ... ,At a meeting of the committee set up to ... city, it was decided to empower police officials of the ... public places by recovering the penalty from the offender on ...
Cached Medicine News:Health News:Look Out for ICE in Emergency Situations 2Health News:New Therapeutic Approach for Autoimmune and Inflammatory Diseases 2Health News:Australia Battles Oil Slick on Yarra River 2Health News:Researchers Developing New Therapy to Re-activate Silenced Genes 2
TD silicone foam compression pad. Use with plates sealed with TDX or OptiTape....
The MicroAmp Centrifuge Adapter accomodates a single MicroAmp Reaction Tube with Cap and fits a standard microcentrifuge rotor. The adapter can be used up to 15,000 x g and should be used in pairs to...
PCR Workstation brings together UV irradiation and antimicrobial stainless steel to create a dual-attack environment against PCR contamination. PCR Workstation now available with a UV/Air Circulator ...
... tube racks. Its camera-based vision system captures and ... rack, making it ideal for use in automated ... a rack to be read automatically and can ... safety switch prevents a rack from being read ...
Medicine Products: